A5024062469- Vaccine Coverage and Hesitancy
- Influenza Virus Research Studies
- COVID-19 Impact on Reproduction
- SARS-CoV-2 and COVID-19 Research
- Respiratory viral infections research
- Congenital Anomalies and Fetal Surgery
- Global Maternal and Child Health
- Pregnancy and Medication Impact
- Folate and B Vitamins Research
- Global Cancer Incidence and Screening
- Reproductive Health and Contraception
- Gestational Diabetes Research and Management
- Digital Radiography and Breast Imaging
- Smoking Behavior and Cessation
- Cervical Cancer and HPV Research
- Health disparities and outcomes
- Pregnancy and preeclampsia studies
- AI in cancer detection
- Breast Cancer Treatment Studies
- Congenital Heart Disease Studies
- COVID-19 and healthcare impacts
- Maternal Mental Health During Pregnancy and Postpartum
- Healthcare Policy and Management
- Bacterial Infections and Vaccines
- Cerebrospinal fluid and hydrocephalus
CDC Foundation
2021-2025
Centers for Disease Control and Prevention
2015-2024
National Center for Immunization and Respiratory Diseases
2020-2024
Oak Ridge Institute for Science and Education
2013-2023
Oak Ridge Associated Universities
2013-2023
HealthPartners
2023
Kaiser Permanente Center for Health Research
2023
Marshfield Clinic
2023
Denver Health Medical Center
2023
University of Colorado Denver
2023
Globally, approximately 170,000 confirmed cases of coronavirus disease 2019 (COVID-19) caused by the novel (SARS-CoV-2) have been reported, including an estimated 7,000 deaths in 150 countries (1). On March 11, 2020, World Health Organization declared COVID-19 outbreak a pandemic (2). Data from China indicated that older adults, particularly those with serious underlying health conditions, are at higher risk for severe COVID-19-associated illness and death than younger persons (3). Although...
Human papillomavirus (HPV) is a known cause of cervical cancers, as well some vulvar, vaginal, penile, oropharyngeal, anal, and rectal cancers (1,2).Although most HPV infections are asymptomatic clear spontaneously, persistent with one 13 oncogenic types can progress to precancer or cancer.To assess the incidence HPV-associated CDC analyzed 2008-2012 high-quality data from CDC's National Program Cancer Registries Institute's Surveillance, Epidemiology, End Results program.During 2008-2012,...
Pregnant women living in or traveling to areas with local mosquito-borne Zika virus transmission are at risk for infection, which can lead severe fetal and infant brain abnormalities microcephaly (1). In February 2016, CDC recommended 1) routine testing infection of asymptomatic pregnant ongoing the first prenatal care visit, 2) retesting during second trimester who initially test negative, 3) signs symptoms consistent disease (e.g., fever, rash, arthralgia, conjunctivitis) any time...
Persons with underlying medical conditions were defined as those who reported having any of the following conditions: cancer; chronic kidney disease; obstructive pulmonary disease (COPD); heart (e.g., failure, coronary artery disease, or cardiomyopathies); immunocompromised state (weakened immune system) from solid organ transplant; obesity; pregnancy; sickle cell smoking; and type 2 diabetes mellitus.Respondents aged 18-64 years reporting diagnosis one more these classified high-risk in...
COVID-19 vaccines are critical for ending the pandemic; however, current data about vaccination coverage and safety in pregnant women limited. Pregnant at increased risk severe illness death from compared with nonpregnant of reproductive age, adverse pregnancy outcomes, such as preterm birth (1-4). eligible can receive any three available United States via Emergency Use Authorization.* Data Vaccine Safety Datalink (VSD), a collaboration between CDC multiple integrated health systems, were...
Abbreviation: COVID-19 = coronavirus disease 2019.* Inpatients include surviving patients whose highest level of care included non-intensive unit hospitalization or intensive with without invasive mechanical ventilation.
Vaccination of pregnant women with influenza vaccine and tetanus toxoid, reduced diphtheria acellular pertussis (Tdap) can decrease the risk for among their infants. The Advisory Committee on Immunization Practices (ACIP) recommends that all who are or might be during season receive vaccine, which administered at any time pregnancy (1). ACIP also Tdap each pregnancy, preferably early part gestational weeks 27-36 (2,3). Despite these recommendations, vaccination coverage has been found to...
Overall, 34% of adults aged 18–39 years reported having received a COVID-19 vaccine. Adults 18–24 years, as well non-Hispanic Black and those with less education, no health insurance, lower household incomes, had the lowest vaccination coverage intent to get vaccinated. Concerns about vaccine safety effectiveness were commonly cited barriers vaccination.
On January 31, 2020, the U.S. Department of Health and Human Services (HHS) declared, under Section 319 Public Service Act, a public health emergency because emergence novel virus, SARS-CoV-2.* After 13 renewals, will expire on May 11, 2023. Authorizations to collect certain data that date as well. Monitoring impact COVID-19 effectiveness prevention control strategies remains priority, number surveillance indicators have been identified facilitate ongoing monitoring. expiration emergency,...
Influenza, tetanus toxoid, reduced diphtheria and acellular pertussis (Tdap), COVID-19 vaccines can reduce the risk for influenza, pertussis, among pregnant women their infants. To assess Tdap, vaccination coverage during 2022-23 influenza season, CDC analyzed data from an Internet panel survey conducted March 28-April 16, 2023. Among 1,814 respondents who were at any time October 2022-January 2023, 47.2% reported receiving vaccine before or pregnancy. 776 with a live birth by date, 55.4%...
COVID-19 vaccine booster doses are safe and maintain protection after receipt of a primary vaccination series reduce the risk for serious COVID-19-related outcomes, including emergency department visits, hospitalization, death (1,2). CDC recommended an updated (bivalent) adolescents aged 12-17 years adults ≥18 on September 1, 2022 (3). The bivalent is formulated to protect against Omicron BA.4 BA.5 subvariants SARS-CoV-2 as well original (ancestral) strain Based data collected during October...
Objective The aim of the study was to evaluate pregnant women's attitudes toward COVID-19 illness and vaccination identify factors associated with vaccine acceptability. Study Design This a cross-sectional survey among women enrolled in prospective cohort Salt Lake City, UT, Birmingham, AL, New York, NY, from August 9 December 10, 2020. Women were eligible if they 18 50 years old <28 weeks gestation. Upon enrollment, completed surveys regarding concerns about likelihood getting one...
Vaccination is critical to controlling the COVID-19 pandemic, and health care providers play an important role in achieving high vaccination coverage (1). To examine prevalence of report a provider recommendation for its association with attitudes, CDC analyzed data among adults aged ≥18 years from National Immunization Survey-Adult COVID Module (NIS-ACM), nationally representative cellular telephone survey. Prevalence increased 34.6%, during April 22-May 29, 40.5%, August 29-September 25,...
Risk for severe coronavirus disease 2019 (COVID-19)-associated illness (illness requiring hospitalization, intensive care unit [ICU] admission, mechanical ventilation, or resulting in death) increases with increasing age as well presence of underlying medical conditions that have shown strong and consistent evidence, including chronic obstructive pulmonary disease, cardiovascular diabetes, kidney obesity (1-4).Identifying describing the prevalence these at local level can help guide...
The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose all persons >18 years of age. We analyzed data from the National Immunization Survey-Adult COVID Module collected during February 27-March 26, 2022 to assess vaccination coverage among adults. used multivariable logistic regression analysis factors associated with vaccination. fully vaccinated adults increased 25.7% in November 2021 63.4% March 2022. Coverage was lower non-Hispanic Black (52.7%),...
We investigated the prevalence of receipt special education services among children with congenital heart defects (CHDs) compared without birth defects.Children born from 1982 to 2004 in metropolitan Atlanta CHDs (n = 3744) were identified a population-based defect surveillance program; 860 715) certificates. Cohorts linked files for 1992-2012 school years identify services. Children noncardiac or genetic syndromes excluded; classified by presence absence critical (ie, requiring intervention...